CRPGF (China Resources Pharmaceutical Group) FFO


CRPGF China Resources Pharmaceutical Group Ltd CRPGF
92 GF Score
Price $0.56
GF Value $0.74
! 3 Warning Signs
View Full Analysis

What is China Resources Pharmaceutical Group FFO?

FFO (Funds from operations) only applies to REITs.

CRPGF
92GF Score
China Resources Pharmaceutical Group Ltd CRPGF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Resources Pharmaceutical Group (CRPGF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued. The current stock price of $0.56 is trading 24.3% below its estimated GF Value™ of $0.74.

Key valuation signals for CRPGF:

  • FFO:
  • GF Value™: $0.74 vs. price of $0.56 (24.3% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the CRPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Resources Pharmaceutical Group Business Description

Other Exchanges 03320:Hong Kong640:Germany
Address 26 Harbour Road, Room 4104-05, 41st Floor, China Resources Building, Wanchai, HKG
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
92GF Score

Get the complete analysis for CRPGF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.74
GF Value